- Home
- GCO vs YMAB Comparison
GCO vs YMAB Comparison
Compare GCO & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCO
- YMAB
- Stock Information
- Founded
- GCO 1924
- YMAB 2015
- Country
- GCO United States
- YMAB United States
- Employees
- GCO N/A
- YMAB N/A
- Industry
- GCO Clothing/Shoe/Accessory Stores
- YMAB Biotechnology: Pharmaceutical Preparations
- Sector
- GCO Consumer Discretionary
- YMAB Health Care
- Exchange
- GCO Nasdaq
- YMAB Nasdaq
- Market Cap
- GCO 212.2M
- YMAB 192.4M
- IPO Year
- GCO N/A
- YMAB 2018
- Fundamental
- Price
- GCO $22.50
- YMAB $4.32
- Analyst Decision
- GCO Hold
- YMAB Buy
- Analyst Count
- GCO 2
- YMAB 11
- Target Price
- GCO $24.50
- YMAB $17.55
- AVG Volume (30 Days)
- GCO 241.0K
- YMAB 182.8K
- Earning Date
- GCO 09-05-2025
- YMAB 08-11-2025
- Dividend Yield
- GCO N/A
- YMAB N/A
- EPS Growth
- GCO N/A
- YMAB N/A
- EPS
- GCO N/A
- YMAB N/A
- Revenue
- GCO $2,341,438,000.00
- YMAB $88,658,000.00
- Revenue This Year
- GCO $2.53
- YMAB N/A
- Revenue Next Year
- GCO $2.01
- YMAB $15.15
- P/E Ratio
- GCO N/A
- YMAB N/A
- Revenue Growth
- GCO 1.85
- YMAB 4.92
- 52 Week Low
- GCO $16.19
- YMAB $3.55
- 52 Week High
- GCO $44.80
- YMAB $16.11
- Technical
- Relative Strength Index (RSI)
- GCO 52.29
- YMAB 43.02
- Support Level
- GCO $21.26
- YMAB $4.23
- Resistance Level
- GCO $24.63
- YMAB $4.62
- Average True Range (ATR)
- GCO 1.06
- YMAB 0.24
- MACD
- GCO 0.20
- YMAB -0.03
- Stochastic Oscillator
- GCO 57.49
- YMAB 14.04
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.